Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents. Its structural configuration supports the creation of bioactive molecules with high selectivity and improved metabolic stability. Commonly employed in the preparation of enzyme inhibitors and receptor modulators, especially in research targeting neurological disorders. The fluorinated cyclohexylamine scaffold enhances blood-brain barrier penetration, making it valuable in medicinal chemistry for optimizing drug candidates. Also utilized in the design of novel antidepressants and antipsychotics due to its influence on pharmacokinetic properties.